Heron Therapeutics Inc. (HRTX)
NASDAQ: HRTX
· Real-Time Price · USD
1.33
-0.02 (-1.48%)
At close: Aug 15, 2025, 3:59 PM
1.33
-0.23%
After-hours: Aug 15, 2025, 05:03 PM EDT
Heron Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.38M | 2.63M | 3.66M | -4.85M | -9.23M | -3.16M | -10.72M | -25.01M | -42.06M | -32.77M | -19.87M | -41.91M | -56.36M | -63.89M | -54.65M | -52.41M | -61.02M | -52.61M |
Depreciation & Amortization | 611K | 551K | 581K | 581K | 641K | 689K | 715K | 727K | 739K | 718K | 791K | 706K | 671K | 721K | 794K | 754K | 734K | 739K |
Stock-Based Compensation | 2.8M | 2.51M | 2.29M | 2.72M | 4.57M | 3.38M | 4.32M | 6.68M | 13.9M | 7.95M | 10.51M | 11.2M | 10.35M | 10.91M | 12.89M | 11.24M | 11.24M | 11.49M |
Other Working Capital | 5.53M | -11.46M | -812K | 709K | -4.03M | -2.14M | 3.47M | -6.89M | 20.3M | -3.96M | -13.01M | -6.82M | 15.35M | 17.29M | -4.02M | -8.5M | -19.77M | -5.94M |
Other Non-Cash Items | 96K | -104K | 24K | -8.6M | 2.84M | -328K | 557K | 73K | 52K | -269K | -445K | -183K | 80K | 297K | 50K | 69K | 283K | 502K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -819K | -184K | -183K | n/a | n/a | n/a | n/a | n/a | 1.05M | 209K | 240K | 128K |
Change in Working Capital | -11.99M | -14.46M | -18.34M | 13.51M | -3.42M | -10.09M | 8.4M | 8.53M | 386K | -528K | -28.52M | -6.88M | 16.88M | 8.02M | -5.4M | -13.03M | -14.47M | -2.18M |
Operating Cash Flow | -10.87M | -8.87M | -11.78M | 3.37M | -4.6M | -9.52M | 2.46M | -9.18M | -27.16M | -24.9M | -37.53M | -37.07M | -28.37M | -43.94M | -45.26M | -53.17M | -62.99M | -41.94M |
Capital Expenditures | -208K | -109K | -638K | -431K | -637K | n/a | -250K | -793K | -278K | -224K | -414K | -45K | -322K | -1.04M | -390K | -1.53M | -315K | -786K |
Cash Acquisitions | 11K | 42K | 27K | n/a | n/a | n/a | 13K | 22.43M | -13.5M | -37.06M | 3K | 168K | -20.08M | 56K | 3.5M | n/a | n/a | n/a |
Purchase of Investments | -9.19M | -22.9M | -12.34M | -25.64M | -27.21M | -37.89M | -23.35M | -35.93M | -14.44M | -13.94M | -18.57M | -68.17M | -20.92M | -38.02M | -37.9M | -29.27M | -17.99M | -44.06M |
Sales Maturities Of Investments | 16.72M | 25.24M | 24.37M | 30.05M | 29.89M | 39.17M | 14.75M | 13.5M | 27.93M | 51M | 21M | 32M | 41M | 49.96M | 14M | 52.44M | 58M | 40.5M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -22.43M | 13.5M | 37.06M | 2.44M | -36M | 20.08M | 56K | -3.47M | 23.16M | 40.01M | -3.56M |
Investing Cash Flow | 7.33M | 2.27M | 11.42M | 3.97M | 2.05M | 1.28M | -8.84M | -23.22M | 13.22M | 36.83M | 2.02M | -36.05M | 19.76M | 10.95M | -24.26M | 21.63M | 39.7M | -4.34M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | -29.75M | 54.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -19K | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -52K | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 781K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 319K | -208K | 439K | 74.94M | 315K | -637K | 487K | n/a | 154.73M | 883K |
Financial Cash Flow | 781K | 64K | 423K | 14K | 492K | 11K | 199K | 53.8M | 319K | -208K | 439K | 74.94M | 315K | -637K | 487K | -71K | 154.73M | 883K |
Net Cash Flow | -2.75M | -6.53M | 61K | 7.36M | -2.06M | -8.23M | -6.18M | 21.4M | -13.63M | 11.73M | -35.07M | 1.83M | -8.3M | -33.63M | -69.03M | -31.6M | 131.43M | -45.4M |
Free Cash Flow | -11.08M | -8.98M | -12.42M | 2.94M | -5.24M | -9.52M | 2.21M | -9.97M | -27.44M | -25.12M | -37.95M | -37.11M | -28.7M | -44.98M | -45.65M | -54.7M | -63.31M | -42.72M |